|
J Biol Chem, Vol. 275, Issue 18, 13597-13604, May 5, 2000
Mammalian Homologues of Yeast Sec31p
AN UBIQUITOUSLY EXPRESSED FORM IS LOCALIZED TO ENDOPLASMIC
RETICULUM (ER) EXIT SITES AND IS ESSENTIAL FOR ER-GOLGI TRANSPORT*
Bor Luen
Tang ,
Tao
Zhang,
Delphine Y. H.
Low,
Ee Tsin
Wong,
Heinrich
Horstmann, and
Wanjin
Hong§
From the Membrane Biology Laboratory, Institute of Molecular and
Cell Biology, 30 Medical Drive,
Singapore 117609, Republic of Singapore
 |
ABSTRACT |
The yeast coat protein II (COPII) is responsible
for vesicle budding from the endoplasmic reticulum (ER). Mammalian
functional homologues for all yeast COPII components, except for
Sec31p, have been reported. We have cloned a mammalian cDNA whose
product (Sec31A) is about 26% identical to Saccharomyces
cerevisiae Sec31p. Data base searches also revealed another
partial sequence encoding a polypeptide (Sec31B) that is 40% identical
to Sec31A. Northern analysis revealed that Sec31A transcripts are
ubiquitously and abundantly expressed, while Sec31B transcripts are
particularly enriched in the testis and thymus, but present in very low
levels in other tissues. Sec31A is localized to vesicular structures that scatter throughout the cell but are concentrated at the
perinuclear region. The structures marked by Sec31A contain Sec13, a
component of COPII that is well characterized to mark the ER exit
sites. Immunoelectron microscopy revealed that Sec31A colocalizes with Sec13 in structures with extensive vesicular-tubular profiles. Antibodies raised against a C-terminal portion of Sec31A co-precipitate Sec13 and inhibit ER-Golgi transport of temperature-arrested vesicular stomatitis G protein in a semi-intact cell assay. Cytosol
immunodepleted of Sec31A failed to support vesicular stomatitis G
protein transport, which can be rescued by a high molecular weight
fraction of the cytosol containing both Sec31A and Sec13. We conclude
that Sec31A represents a functional mammalian homologue of yeast Sec31p.
 |
INTRODUCTION |
Our understanding of membrane transport in eukaryotic cells has
benefited from combined genetic and biochemical approaches in yeast
Saccharomyces cerevisiae (1, 2). For vesicle budding from
the endoplasmic reticulum
(ER),1 the isolation and
characterization of conditional lethal sec mutants (2, 3)
and the development of in vitro ER budding and ER-Golgi
transport assays (1) had allowed the subsequent molecular and
biochemical characterization of the machinery (4-8) responsible for
vesicle formation from the ER. Vesicle formation from yeast microsomal
membranes has been reconstituted in vitro with three
purified components from yeast cytosol, Sar1p, Sec23p·Sec24p complex,
and Sec13p·Sec31p complex (9). Together, these proteins form the
COPII coat complex (10, 11). They represent a set of coat proteins
functioning in the early secretory pathway which are distinct from the
COPI coat complex, first discovered in mammalian cells and have been
proposed to mediate anterograde and retrograde transport in the
secretory pathway (11-13).
The first mechanistic understanding of the function of various
components of COPII with regard to vesicle formation came from the
yeast system (14). In the initiation of COPII vesicle budding, the
small GTPase Sar1p (6) is first recruited onto the ER membrane, at
least in part, through a guanine nucleotide exchange reaction catalyzed
by the ER membrane protein Sec12p (6). Sar1p on the membrane then
recruits the Sec23p·Sec24p complex (15). Sec23p is a
GTPase-activating protein of Sar1p (16). The resulting Sar1p-Sec23p·Sec24p complex appears to be important for cargo binding
(14). Although tightly associated with Sec23p in the cytosol, Sec24p
apparently does not influence the GTPase-activating protein activity of
Sec23p and its exact function is unclear (15). Subsequent recruitment
of the WD-40 repeat containing (17) Sec13p·Sec31p complex leads to
vesicle formation, although the exact mechanistic function of the
Sec13p·Sec31p complex in vesicle budding is unclear (11). These COPII
components are sufficient to drive vesicle formation from chemically
defined liposomes (18, 19).
Most of the corresponding mammalian homologs of yeast COPII components
have now been cloned, except for Sec31p. In most cases, there exist
multiple mammalian forms of a corresponding COPII component in yeast.
There are two isoforms of mammalian Sar1 (20) and Sec23 (21). We and
others have recently reported the cloning of four isoforms of mammalian
Sec24 (22-24). A single form of mammalian Sec13 have been reported so
far (25), although there exist yeast proteins homologous to Sec13p
(28). We now report the existence of two mammalian proteins that are
homologous to yeast Sec31p, one (Sec31A) that is abundantly and
ubiquitously expressed while the other (Sec31B) is enriched in the
testis and thymus. The morphological, biochemical, and functional
characterization of Sec31A suggest that it is indeed a component of
mammalian COPII involved in ER-Golgi transport.
 |
MATERIALS AND METHODS |
Clones and Constructs--
Data base searches were performed
with the various Basic Local Alignment Search Tools (BLAST) algorithms
(27, 28) available at the National Center for Biotechnology (NCBI)
World Wide Web server. Expressed sequence tag (EST) clones were
generated by the Washington University-MERCK EST projects, and were
obtained from the IMAGE consortium via Research Genetics Inc. The
Sec31B partial clone was obtained from the Resource Center, German
Human Genome Project, German Cancer Research Center (DKFZ) (designated DKFZp434M183). Library screening, cloning, and DNA sequencing were
performed using standard methods as described (29). The EcoRI-NotI insert of an EST clone (GenBank
accession number AA423899) was 32P-labeled and used as a
probe to screen a human pancreas UniZap cDNA library (Strategene)
by DNA in situ hybridization. Positive clones with insert
sizes larger than 3 kilobase were sequenced.
Polymerase chain reactions were carried out using high fidelity Pfu
polymerase from Strategene. Fragments of the cDNA obtained were
generated by polymerase chain reaction and cloned into pGEX-4T vector
(Amersham Pharmacia Biotech) for the production of fusion proteins in bacteria.
Northern blot analyses were performed using human multiple tissue
Northern (MTN) blots from CLONTECH (Palo Alto, CA).
A full-length cDNA is used as a probe for Sec31A. For Sec31B, a
fragment of about 500 base pairs corresponding to a non-homologous
region of Sec31B to Sec31A was generated by polymerase chain reaction and used as a probe.
Antibodies--
Polyclonal antibody against mammalian Sec13 has
been described previously (8). Antiserum against human Sec23A is kindly provided by Dr Jean-Pierre Paccaud (University of Geneva Medical Center, Switzerland) (21). Polyclonal antibodies against Sec31A in this
study were obtained by immunization of mice and rabbits with a soluble
glutathione S-transferase fusion construct corresponding to
the C-terminal 180 amino acids of the Sec31 coding region.
Immunofluorescence Microscopy--
Cells were maintained in RPMI
medium supplemented with 10% fetal bovine serum. Immunofluorescence
microscopy was performed as described previously (8, 25). Cells plated
on coverslips were fixed with 4% paraformaldehyde followed by
sequential incubation with the primary antibodies and fluorescein
isothiocyanate or rhodamine-conjugated secondary antibodies.
Fluorescence labeling was visualized using an Axiophot microscope (Carl
Zeiss, Inc., Thornwood, NY) with epifluorescence optics or MRC1024
(Bio-Rad) confocal laser optics.
Electron Microscopy--
Cryosectioning and immunogold labeling
for electron microscopy were performed as described previously (8, 30,
31).
ER-Golgi Transport Assay--
The ER to Golgi transport assay
using semi-intact cells was performed as described previously (8,
32-35). Briefly, normal rat kidney cells were grown on 10-cm dishes to
confluence and infected with the temperature-sensitive strain of the
vesicular stomatitis virus, VSVts045 at 32 °C for 3-4 h. The cells
were then pulse-labeled with [35S]methionine (100 µCi/ml) at the restrictive temperature (40 °C) for 10 min and
perforated on ice by hypotonic swelling and scraping. These semi-intact
cells were then incubated in a complete assay mixture of 40 µl
containing 25 mM HEPES-KOH, pH 7.2, 90 mM
potassium acetate, 2.5 mM magnesium acetate, 5 mM EGTA, 1.8 mM calcium chloride, 1 mM ATP, 5 mM creatine phosphate, 0.2 IU of
rabbit muscle creatine phosphokinase, 25 µg of rat liver cytosol, and
5 µl (25-30 µg) of protein for 1-2 × 105) of
semi-intact cells. For a standard assay, samples were incubated for 90 min at 32 °C and transport terminated by transferring to ice. The
membranes were collected by a brief spin and solubilized in 60 µl of
0.2% SDS, 50 mM sodium citrate, pH 5.5. After boiling for
5 min, the samples were digested overnight at 37 °C in the presence
of 2.5 units of endoglycosidase H (endo H), and the reaction was
terminated by adding 5× concentrated gel sample buffer. The samples
were analyzed on 7.5% SDS-polyacrylamide gels and quantified using the
PhosphorImager (Molecular Dynamics, Sunnyvale, CA). For antibody
inhibition of transport assay, antibodies were added into the complete
assay mixture and incubated on ice for 60 min to allow the antibodies
to first diffuse completely into the semi-intact cells.
 |
RESULTS |
Molecular Cloning of Sec31--
Data base searches using the yeast
Sec31p sequence (7, 36) revealed several human EST clones encoding
polypeptides with significant homology to Sec31p outside the WD-40
repeat region. We screened a human pancreas cDNA library using the
insert from one of these ESTs (GenBank number AA423899) as a probe. DNA sequencing of positive clones revealed an open reading frame of 1218 amino acids. Alignment of the amino acid sequences of this mammalian
protein with Sec31p is shown in Fig.
1A. It shares 25.8% identity
with Sec31p, with homology throughout the entire coding region. Five
WD-40 or WD-40-like repeats are present at the N terminus. There is a
region enriched in proline residues in the C-terminal half. These
features are similar to the domain profile of Sec31p. Although the
homology between this protein and Sec31p is not as high as those found
between Sar1p as well as Sec23p and their mammalian homologues (about
50%), the domain similarities suggest that this protein is a candidate
for a mammalian homologue of Sec31p. We have therefore tentatively
named this protein Sec31A.

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 1.
A, alignment of the amino acid sequences
of Sec31A with the yeast Sec31p (MegAlign program of DNASTAR).
Identical residues of these two proteins are shaded.
B, table indicating the percentage of similarity and
divergence of Sec31p homologues in several species aligned by the
MegAlign program of DNASTAR. Shown here are the S. cerevisiae Sec31p (U15219), a Schizosaccharomyces
pombe homologue (AB004537), and a C. elegans
homologue (CE16320). Also in the data base but not shown here are a
full-length human cDNA KIAA0905 (AB020712) deposited by the Kazusa
DNA Research Institute and two alternatively spliced human cDNA
(AB018358 and AB018359) deposited by M. Shibata (Medical and Biological
Laboratories Co. Ltd., Nagano, Japan). There is also a rat orthologue
that is about 90% homologous to the human Sec31A (Shugrue C. A. et al., Yale University School of Medicine (40)) and a
partial human cDNA clone (DKFZp434M183, Wambutt et al.,
German Cancer Research Center) encoding a polypeptide (Sec31B) sharing
40% amino acid identity with Sec31A. C, domain structure of
Sec31A protein. Sec31A, like its yeast counterparts, have a N-terminal
region consisting of WD-40 repeats. There is a proline-rich region at
the C-terminal half. Between these two regions, there is an intervening
region without any distinct functional domain structure.
|
|
Data base search using the Sec31A sequence also revealed homology with
a S. pombe and a Caenorhabditis
elegans protein (Fig. 1B). These proteins also
contained a region of WD-40 repeats at the N terminus and a stretch of
proline-rich sequence in the C-terminal half. The most recent data base
search also revealed identical full-length human clones, an
alternatively spliced product, and a rat orthologue cDNA. Most
interestingly, we have also identified a partial human cDNA
(DKFZp434M183) encoding a 915-residue polypeptide (tentatively named
Sec31B) that is about 40% identical to the C-terminal two-thirds of
Sec31A. DKFZp434M183 was cloned from testis and subsequently made
available to us by the Resource Center, German Human Genome Project,
German Cancer Research Center.
Northern blot analysis for Sec31A revealed a transcript of about 4 kilobases in length that is abundantly and ubiquitously expressed in
all tissues examined (Fig. 2). Ubiquitous
expression is indeed a feature expected of an essential molecule like
Sec31. We have also investigated the expression pattern of Sec31B using a polymerase chain reaction-generated fragment to a region that bears
no homology to Sec31A. The Sec31B transcript is about 6.5 kilobases and
is present at very low levels in most tissues compared with Sec31A.
Further analysis with a different tissue panel showed that the Sec31B
transcripts are particularly enriched in the thymus and testis. This
finding explains our failure in finding other ESTs (except those from
the same testis library) corresponding to Sec31B.
Subcellular Localization of Mammalian Sec31--
Sec31A bears a
relatively low homology to yeast Sec31p, while the homology of
mammalian Sar1 and Sec23 to their respective yeast counterparts is much
higher. This relatively weak homology brings into question as to
whether Sec31A is a functional homologue of Sec31p. To facilitate our
morphological, biochemical, and functional characterization of Sec31A,
antibodies were raised in both mice and rabbits using a recombinant
fragment representing the C-terminal portion Sec31A. Both mouse (not
shown) and rabbit antisera detected a protein of about 150 kDa in all
primate and rodent cells examined (Fig.
3A), which is in agreement
with the size of the in vitro translated product. Indirect
immunofluorescence revealed that Sec31A is associated with vesicular
structures that are concentrated at the perinuclear region but are also
found scattered at the cell periphery (Fig. 3B).

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 3.
A, affinity-purified rabbit antibodies
against Sec31 recognized a major polypeptide of about 150 kDa, which is
in agreement with the size of the [35S]methionine labeled
in vitro translation product (arrow). The mouse
antiserum recognized a protein of the same size (not shown). The lower
molecular size polypeptides in the translation mixture are probably
generated by internal initiation. It is not clear whether the lower
band of about 55 kDa detected by the Sec31A antibodies correspond to a
cross-reacting protein or an endoproteolytic product of Sec31A. It is
also not clear whether the doublet bands in Chinese hamster ovary
(CHO) cell lysates represents alternatively spliced forms.
B, localization of the Sec31A in cells of different species
by indirect immunofluorescence microscopy. Chinese hamster ovary
(hamster), HeLa (human), or Vero (simian) cells were fixed with 4%
paraformaldehyde and incubated with mouse antiserum against Sec31A,
followed by incubation with fluorescein isothiocyanate-labeled
anti-mouse IgG. Bar, 10 µm.
|
|
The staining pattern of Sec31A is highly reminiscent of that for
mammalian Sar1 (20), Sec13 (8), Sec23A (22), and Sec24 (22), which is
characteristic of ER exit sites (37). Indeed, double labeling using
mouse antiserum against Sec31A and rabbit polyclonal antibodies against
Sec13 showed that Sec31A colocalized well with Sec13 (Fig.
4A). Colocalization of Sec31A
with an established component of mammalian COPII (Sec13) strongly
supports the notion that Sec31A is also a COPII component.

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 4.
A, colocalization of Sec31A with Sec13.
Normal rat kidney cells were fixed with 4% paraformaldehyde and
incubated with mouse antiserum against Sec31A and rabbit polyclonal
antibodies against Sec13, followed by incubation with fluorescein
isothiocyanate-labeled anti-mouse IgG and rhodamine-labeled anti-rabbit
IgG. The upper panels are at a lower magnification, and the
lower panels represent a single cell at a higher
magnification. Bar, 10 µm. B,
GTP S-dependent recruitment of Sec31A onto membrane
structures in permeabilized cells. Cells were permeabilized with 20 µg of digitonin in 25 mM Hepes, pH 7.3, and 125 mM potassium acetate followed by extensive washings with
the same buffer. Rat liver cytosol was then added to the cells with and
without 1 µM GTP S and incubated at 37 °C for 30 min. The cells were than washed, fixed with 4% paraformaldehyde, and
incubated with mouse antiserum against Sec31A followed by incubation
with fluorescein isothiocyanate-labeled anti-mouse IgG. Bar,
10 µm.
|
|
Coat components in both yeast and mammalian cells are recruited onto
the membrane in a GTP-dependent manner. In the cases of
COPI and COPII, component recruitment is initiated, respectively, by
the binding and activation of the small GTPases Arf and Sar1 by their
respective guanine nucleotide exchange proteins on the membrane. The
localization of Sec31A on Sec13 positive membrane structures prompted
us to examine if its membrane recruitment is GTP-dependent.
The membrane labeling is lost or greatly diminished when cells are
permeabilized with digitonin and washed extensively (Fig.
4B). This indicates that Sec31A is not tightly associated with the membrane. The very prominent localization of the protein on
the membrane under steady state conditions in vivo is
probably dependent on constant recruitment from the cytosol. When the
permeabilized and washed cells are incubated with cytosol, binding of
the protein to specific membrane structures can be observed, suggesting
that there is a specific recruitment process rather than nonspecific binding. The signal observed, however, is weak compared with that in
normal, unpermeabilized cells. The level of membrane association of
Sec31A is greatly enhanced, approximating that in normal cells, when
0.1 µM of the nonhydrolysable GTP analog GTP S is added
to the incubation. These results indicate that recruitment of Sec31A onto membrane structures marked by Sec13 is
GTP-dependent.
We further examined the subcellular localization of Sec31A at the
ultrastructural level. Double immunogold labeling of Sec31A and Sec13
revealed that they are both enriched in structures with a vesiculated
membrane profile around the Golgi apparatus (Fig. 5). This is consistent with the results
obtained at the light microscopy level. Examination at a higher
magnification showed that the structures in which both Sec13 and Sec31A
are concentrated appear to consist of buds, vesicles, and tubules.
These structures are likely to be the sites of COPII vesicle budding
from the ER.

View larger version (204K):
[in this window]
[in a new window]
|
Fig. 5.
Colocalization of Sec31A and Sec13 at the
ultrastructural level. Vesiculated profiles enriched in both
Sec31A (14-nm gold particles) and Sec13 (10-nm gold particles) are
frequently found around the Golgi apparatus (labeled G)
(a). These structures appear to be enriched in buds,
vesicles, and tubules (b-d). Panel b is a
magnified view of the Sec13/Sec31A containing structures shown in
panel a. Bar, 0.1 µm.
|
|
Sec31A Exists as a High Molecular Weight Complex with
Sec13--
The colocalization of Sec31A with Sec13 led us to examine
whether the two proteins interact in vivo. As shown in Fig.
6, antibodies against Sec31A
co-precipitates the 36-kDa Sec13. In the reciprocal experiment,
antibodies against Sec13 (8) co-precipitates the 150-kDa Sec31A. This
interaction between Sec31A and Sec13 manifested by
co-immunoprecipitation is specific because Sec23, another COPII component in the cytosol, does not co-precipitate with either Sec31A or
Sec13 under the same conditions.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 6.
Sec31A interacts physically with Sec13 but
not Sec23 in the cytosol. Rat liver cytosol was immunoprecipitated
with rabbit polyclonal antibody against Sec31A (A and
D) or Sec13 (B and C). The
immunoprecipitates were eluted in SDS-PAGE sample buffer and subjected
to SDS-PAGE together with 1/25th of the cytosol used in
each immunoprecipitation. The proteins were transferred to
nitrocellulose and immunoblotted using affinity-purified rabbit
polyclonal antibodies against Sec13 (A), Sec31A
(B), or antiserum against Sec23A (C and
D) (21). The molecular sizes of markers used (in kDa) were
indicated on the left of each panel, and arrows
on the right point to the detected bands of interest as well as the
immunoglobulin heavy chain (IgH). In panel E, rat liver
cytosol was fractionated by gel filtration on a Superose 6 column. The
fractions were precipitated by 10% trichloroacetic acid and equivalent
amounts of each were subjected to SDS-PAGE and immunoblotting using
either the mouse antiserum against Sec31A or rabbit polyclonal
antibodies against Sec13. Fractions at which molecular size markers
peaked are indicated.
|
|
We further examined the Sec13·Sec31A complex by gel filtration. When
rat liver cytosol was subjected to gel filtration in a Superose 6 medium (Amersham Pharmacia Biotech), the majority of Sec13 as well as
Sec31A were fractionated to high molecular weight fractions of about
600-700 kDa (Fig. 6E). A very small fraction of each is
also found in low molecular weight fractions with sizes corresponding
to monomeric forms of the respective proteins.
In view of the fact that Sec13 and Sec31A exists essentially in a
complex in the cytosol, we have estimated their interaction stoichiometry based on the incorporation of
[35S]methionine into the polypeptides. HeLa cells starved
in medium without methionine was subsequently incubated for 5 h in
medium containing 0.25 mCi/ml [35S]methionine. Lysates of
the cells were subjected to immunoprecipitation with antibody against
Sec13 and antibody against Sec31A. When resolved on a SDS-PAGE gel,
both immunoprecipitates contain bands corresponding to Sec13 (36 kDa)
and Sec31A (150 kDa) in similar ratios, and subsequent quantitation of
the bands by scintillation counting revealed an approximate 1:1
stoichiometry of the two proteins.
Sec31 Is Essential for ER-Golgi Transport--
The subcellular
colocalization and biochemical interaction between the Sec31A and Sec13
strongly suggest that Sec31A may represent the functional counterpart
of yeast Sec31p. We have therefore sought further functional evidence
for the involvement of Sec31A in ER-Golgi transport.
We used a permeabilized cell system monitoring the transport of
temperature-synchronized vesicular stomatitis virus (ts045 strain) G
protein (VSVG) (8, 32, 34-35). As shown in Fig. 7A, the fusion protein between
the C-terminal 180 amino acids of Sec31A and GST (GST-Sec31A) inhibited
VSVG transport, as does GST-Sec22B (34), whereas GST itself had no
effect. Antibodies raised against GST-Sec31A also inhibited transport,
as do antibodies against Bet1 (35) and Sec22B (34), whereas control
rabbit IgG has no effect. The inhibitory activity of Sec31A antibodies could be inactivated by heat denaturation (not shown). The fact that
antibodies against Sec31A inhibit ER-Golgi transport as do antibodies
against SNARE molecules like Bet1 (35), Sec22B (34), and GS28 (38)
strongly suggest that Sec31A is involved in ER-Golgi transport.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 7.
Sec31A is essential for ER-Golgi transport.
A, transport assay mixtures were supplemented with GST,
GST-Sec31A, GST-Sec22B, rabbit IgG, or antibodies against Sec31A, Bet1
(35), or Sec22B (34). Transport reactions and processing were carried
out as described under "Materials and Methods." The lower band
corresponds to the endo H-sensitive ER form of VSVG, and the
upper band corresponds to the endo H-resistant Golgi form.
The ratio of the intensities of the upper band and
lower band is a measure of transport of VSVG from the ER to
the Golgi. The respective values of which are plotted on the graph.
B, essential role of cytosolic Sec31A in ER-Golgi transport.
Immunodepletion of rat liver cytosol was carried out by incubating
cytosol with protein A-Sepharose beads coated with Sec31A antibodies or
rabbit IgG (mock depletion). The extends of the depletions were
determined by quantitative immunoblot with Sec31A antibodies
(upper panel). Transport assay mixtures were supplemented
with increasing amounts of Sec31A-depleted or mock-depleted cytosol,
and the resulting ratios of the Golgi versus the ER form
were plotted on the graph below (filled squares,
mock-depleted cytosol; filled circles, Sec31A-depleted
cytosol). C, rat liver cytosol was fractionated by gel
filtration on a Superose 6 column. The high molecular size peak
fractions containing Sec31A as determined by immunoblotting were than
used in transport assays (HMF-high molecular size fraction; Dep.
Cytosol-immunodepleted cytosol). The amounts of cytosol and HMF used to
supplement the Dep. cytosol contained equivalent amounts of Sec31A, as
determined by quantitative immunoblot (not shown).
|
|
We next examine if the presence of Sec31A in the cytosol is essential
for ER-Golgi transport. To do this, we immunodepleted Sec31A from rat
liver cytosol and compared the efficacy of the Sec31A-depleted cytosol
in supporting VSVG transport to cytosol mock-depleted with rabbit IgG.
As shown in Fig. 7B, Sec31A-depleted cytosol was unable to
support VSVG transport to any significant level even at high concentrations.
Sec31A, in complex with Sec13, is likely to be the missing ingredient
from the Sec31A-depleted cytosol that resulted in lost of transport
activity. To prove this, we checked if the high molecular weight
fraction enriched in Sec31A and Sec13 could restore the transport
activity of Sec31A-depleted cytosol. As shown in Fig. 7C,
the Sec31A depleted-cytosol and the high molecular size fraction by
themselves do not support transport. However, addition of the high
molecular size fraction to Sec31A-depleted cytosol efficiently restores
its transport activity, to a level comparable to that of normal
cytosol. The above results suggest that Sec31A is essential for the
ER-Golgi transport of VSVG.
 |
DISCUSSION |
Mammalian Homologues of Yeast Sec31p--
Sec31p was first
discovered as a 150-kDa protein interacting with Sec13p in the yeast
cytosol (39), and was shown biochemically to be essential for vesicle
formation from the ER (9, 39). The SEC31 gene was
subsequently cloned by complementation of the temperature sensitive
Sec31-1 allele (7). SEC31 was also cloned separately as WEB1, allele-specific mutations of which lead
to growth dependence on the adenovirus E1A protein (36).
In this report, we described two mammalian proteins that are homologous
to Sec31p. Sec31A is abundantly and ubiquitously expressed, while
Sec31B is enriched in the thymus and testis. Although sharing a mere
26% homology to yeast Sec31p, three lines of evidence suggest that
Sec31A is a functional counterpart of Sec31p. First, Sec31A colocalized
well with Sec13. Without any recognizable hydrophobic sequences that
would serve as a membrane anchor, Sec31A nevertheless showed membrane
staining patterns which are very similar to that of other known
mammalian COPII components (8, 20-22). This suggests that they were
recruited to the same membrane structures, a fact that is further
verified by the observation at the ultrastructural level that both
Sec31A and Sec13 are present in vesicular-tubular structures
characteristic of the ER exit sites. Moreover, like Sec13 and other
COPII components, recruitment of Sec31A to membranes is
GTP-dependent, and recruitment in permeabilized cells is
greatly enhanced by the nonhydrolysable analog GTP S.
Second, Sec31A exists in a protein complex with Sec13. In the cytosol,
antibodies against Sec31A and antibodies against Sec13 can reciprocally
co-immunoprecipitate one another. On the other hand, Sec23, whose yeast
counterpart Sec23p has been shown to be in a different complex (the
Sec23p-Sec24p complex) in the cytosol (15), could not be
co-immunoprecipitated by either antibodies. Sec31A also cofractionates
with Sec13 to a high molecular weight fraction, as determined by gel
filtration analysis of rat liver cytosol. It is interesting to note
that the high molecular weight complex of Sec31A and Sec13 could not be
formed easily in vitro, for example, by simply mixing the
in vitro translation products of Sec31A and Sec13 (data not
shown). The cytosolic environment may therefore aid complex formation
in vivo, perhaps also with the help of chaperone proteins.
Finally, we demonstrated that Sec31A is essential for ER-Golgi
transport. Both the C-terminal 180-amino acid fusion protein as well as
antibodies against Sec31A inhibited ER-Golgi transport of VSVG in a
semi-intact cell system. Immunodepletion of Sec31A from the cytosol
impaired its ability to support transport. This impairment could be
rescued by the high molecular fractions containing Sec31A and Sec13.
Taken together, the evidence for Sec31A being a mammalian equivalent of
yeast Sec31p is compelling.
It appears that most mammalian COPII components have more isoforms than
their yeast counterparts. This is probably a reflection of the higher
level of sophistication and complexity in the mammalian machinery and
also perhaps a need to delegate the recruitment of specific subsets of
cargo proteins to combinations of different COPII components. It is not
difficult to envisage that in cells specializing in the secretion of
particular proteins, there may exist cell type-specific isoforms of a
general component of the transport machinery. However, it is not clear
at present if the thymus and testis-enriched Sec31B functions in COPII
vesicle formation. While this report is under review, Shugrue et
al. (40) reported the cloning and characterization of a rat
protein, p137, that bears about 90% identity to Sec31A. The rat
protein is also ubiquitously expressed in rat tissues and is very
likely the rat orthologue of human Sec31A.
Interaction of Sec31A with Sec13 and Other Proteins--
The coat
protein complexes responsible for vesicle budding in the early
secretory pathway share a similar feature in the mechanism of membrane
recruitment, via the activation and membrane recruitment of a small
GTPase. The components of the COPI complex exist in the cytosol as a
seven-polypeptide complex (known as the coatomer) and is recruited
en bloc onto the membrane via activation of Arf (41). In
contrast, COPII proteins exist as smaller subcomplexes in the cytosol
and are sequentially recruited onto the membrane (9, 14, 42). Although
the Sec23-24 complex together with activated Sar1 are apparently
important for the recruitment of cargo proteins to the budding sites
(14, 42), the role of subsequent binding of Sec13·Sec31 complex is
unknown. It is speculated that these proteins perhaps serve a function
analogous to that of clathrin triskelons in clathrin-coated vesicles
(43), in that they may cluster bound components together with cargo
molecules into the shape of coated vesicles. In support of this, yeast
Sec31p has been shown to interact directly with both Sec23p and Sec24p in vitro as well as in the context of the yeast two-hybrid
system (44). It may also be relevant to note that the native
Sec13·Sec31 complex is large, presumably multimeric, and will be well
suited for the proposed function.
It has also been shown that yeast Sec31p interacts with Sec16p, a
peripheral membrane protein tightly associated with the ER membrane
(44). Sec16p, which also binds to Sec23p and Sec24p, is a large
multidomain protein which may serve a docking function in bringing all
the COPII components together (45). Although the mammalian homologue of
Sec16p has not yet been cloned, its existence was recently demonstrated
as a band immunologically related to Sec16p in a GST-Sec23 pull-down
experiment (46). It is interesting that the domain responsible for
interacting with Sec16p was mapped to the C terminus of Sec31p, as it
may account for the transport inhibitory effect of the C-terminal fusion protein as well as the antibodies against this region of Sec31A.
The mechanism of inhibition, however, is probably more than a simple
inhibition of binding or recruitment, as the antibody does not inhibit
the recruitment of the Sec13·Sec31 complex onto membranes in
vitro (data not shown).
The Sec13p·Sec31p complex in the yeast cytosol appears to consist of
only those two proteins (39), and we have not yet been able to identify
any other proteins that may be associated with the Sec13·Sec31A
complex in rat liver cytosol. It may be that interactions of other
proteins with the Sec13·Sec31A complex in the cytosol are not robust
enough to be detected by coprecipitation methods. However, both Sec13
and Sec31A may well interact with proteins other than Sec23 and Sec24
when recruited onto the membrane. In fact, our immunoprecipitation of
[35S]methionine-labeled total cell lystes with either
antibodies against Sec13 or Sec31A revealed several bands with
molecular sizes distinct from Sec23, Sec24, or Sar1 (data not shown).
There is a precedence for interactions of COPII components with other
proteins in a Sar1-independent manner. Sec23A has been recently shown
to interact directly with p125, a protein with homology to
phospholipid-modifying proteins (46). Yeast Sec24p has been shown to
interact specifically with the cis-Golgi syntaxin Sed5p (47). The WD-40
repeats at the N terminus of Sec31 are known motifs for protein-protein
interaction. This domain of Sec31p presumably interacts with Sec13p
(36), but may well bind other proteins. The C-terminal half of Sec31A
contains a proline-rich region with several SH3 binding consensus sites
(XPXXP) (48). As the last complex of COPII to be
recruited onto membranes prior to vesicle formation, it makes sense to
link this complex to regulatory mechanisms. It would not, therefore, be
surprising if Sec31 interacts with other proteins regulating COPII
vesicle formation.
 |
ACKNOWLEDGEMENT |
We thank Dr Jean-Pierre Paccaud (University of
Geneva Medical Center, Switzerland) for antiserum against human Sec23A.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) of Sec31A reported in this paper has been
submitted to GenBankTM/EBI Data Bank with the accession
number(s) AF139184.
To whom correspondence should be addressed. Tel.: 65-874-3793;
Fax: 65-779-1117; E-mail: mcbtbl@imcb.nus.edu.sg.
§
Supported by a research grant from the Institute of Molecular and
Cell Biology. To whom correspondence should be addressed. Tel.:
65-874-3762; Fax: 65-779-1117; E-mail: mcbhwj@imcb.nus.edu.sg.
 |
ABBREVIATIONS |
The abbreviations used are:
ER, endoplasmic
reticulum;
EST, expressed tag sequence;
GTP S, guanosine
5'-O-(thiotriphosphate);
PAGE, polyacrylamide gel
electrophoresis;
VSVG, vesicular stomatitis G protein;
GST, glutathione
S-transferase.
 |
REFERENCES |
| 1.
|
Baker, D.,
Hicke, L.,
Rexach, M.,
Schleyer, M.,
and Schekman, R.
(1988)
Cell
54,
335-344[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Novick, P.,
Field, C.,
and Schekman, R.
(1980)
Cell
21,
205-215[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Kaiser, C. A.,
and Schekman, R.
(1990)
Cell
61,
723-733[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Barlowe, C.,
and Schekman, R.
(1993)
Nature
365,
347-349[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Espenshade, P.,
Gimeno, R. E.,
Holzmacher, E.,
Teung, P.,
and Kaiser, C. A.
(1995)
J. Cell Biol.
131,
311-324[Abstract/Free Full Text]
|
| 6.
|
Nakano, A.,
and Muramatsu, M.
(1989)
J. Cell Biol.
109,
2677-2691[Abstract/Free Full Text]
|
| 7.
|
Salama, N. R.,
Chuang, J. S.,
and Schekman, R.
(1997)
Mol. Biol. Cell
8,
205-217[Abstract]
|
| 8.
|
Tang, B. L.,
Peter, F.,
Krijnse-Locker, J.,
Low, S. H.,
Griffiths, G.,
and Hong, W.
(1997)
Mol. Cell. Biol.
17,
256-266[Abstract]
|
| 9.
|
Salama, N.,
Yeung, R. T.,
and Schekman, R.
(1993)
EMBO J.
12,
4073-4082[Medline]
[Order article via Infotrieve]
|
| 10.
|
Barlowe, C.,
Orci, L.,
Yeung, T.,
Hosobuchi, M.,
Hamamoto, S.,
Salama, N.,
Rexach, M. F.,
Ravazzola, M.,
Amherdt, M.,
and Schekman, R.
(1994)
Cell
77,
895-907[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Barlowe, C.
(1998)
Biochim. Biophys. Acta
1404,
67-76[Medline]
[Order article via Infotrieve]
|
| 12.
|
Rothman, J. E.,
and Wieland, F. T.
(1996)
Science
272,
227-234[Abstract]
|
| 13.
|
Schekman, R.,
and Orci, L.
(1996)
Science
271,
1526-1533[Abstract]
|
| 14.
|
Kuehn, M. J.,
Herrmann, J. M.,
and Schekman, R.
(1998)
Nature
391,
187-190[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Hicke, L.,
Barlowe, C.,
and Schekman, R.
(1992)
Mol. Biol. Cell
3,
667-676[Abstract]
|
| 16.
|
Yoshihisa, T.,
Barlowe, C.,
and Schekman, R.
(1993)
Science
259,
1466-1468[Abstract/Free Full Text]
|
| 17.
|
Garcia-Higuera, I.,
Fenoglio, J.,
Li, Y.,
Lewis, C.,
Panchenko, M. P.,
Reiner, O.,
Smith, T. F.,
and Neer, E. J.
(1996)
Biochemistry
35,
13985-94[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Matsuoka, K.,
Orci, L.,
Amherdt, M.,
Bednarek, S. Y.,
Hamamoto, S.,
Schekman, R.,
and Yeung, T.
(1998)
Cell
93,
263-275[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Matsuoka, K.,
Morimitsu, Y.,
Uchida, K.,
and Schekman, R.
(1998)
Mol. Cell.
2,
703-708[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Kuge, O.,
Dasher, C.,
Orci, L.,
Rowe, T.,
Amherdt, M.,
Plutner, H.,
Ravazzola, M.,
Tanigawa, T.,
Rothman, J. E.,
and Balch, W. E.
(1994)
J. Cell Biol.
125,
51-65[Abstract/Free Full Text]
|
| 21.
|
Paccaud, J. P.,
Reith, W.,
Carpentier, J. L.,
Ravazzola, M.,
Amherdt, M.,
Schekman, R.,
and Orci, L.
(1996)
Mol. Biol. Cell
7,
1535-1546[Abstract]
|
| 22.
|
Pagano, A.,
Letourneur, F.,
Garcia-Estefania, D.,
Carpentier, J.-L.,
Orci, L.,
and Paccaud, J.-P.
(1999)
J. Biol. Chem.
274,
7833-7840[Abstract/Free Full Text]
|
| 23.
|
Tani, K.,
Oyama, Y.,
Hatsuzawa, K.,
and Tagaya, M.
(1999)
FEBS Lett.
447,
247-250[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Tang, B. L.,
Kausalya, J.,
Low, D. Y. H.,
Lock, M. L.,
and Hong, W.
(1999)
Biochem. Biophys. Res. Commun.
258,
679-684[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Shaywitz, D. A.,
Orci, L.,
Ravazzola, M.,
Swaroop, A.,
and Kaiser, C. A.
(1995)
J. Cell Biol.
128,
769-777[Abstract/Free Full Text]
|
| 26.
|
Siniossoglou, S,
Wimmer, C.,
Rieger, M.,
Doye, V.,
Tekotte, H.,
Weise, C.,
Emig, S.,
Segref, A.,
and Hurt, E. C.
(1996)
Cell
84,
265-275[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Altschul, S. F.,
Madden, T. L.,
Schäffer, A. A.,
Zhang, J.,
Zhang, Z.,
Miller, W.,
and Lipman, D. J.
(1997)
Nucleic Acids Res.
25,
3389-3402[Abstract/Free Full Text]
|
| 28.
|
Altschul, S. F.,
Gish, W.,
Miller, W.,
Myers, E. W.,
and Lipman, D. J.
(1990)
J. Mol. Biol.
215,
403-410[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K.
(eds)
(1993)
Current Protocols in Molecualr Biology
, Greene Publishing and Wiley Interscience, New York
|
| 30.
|
Griffiths, G.
(ed)
(1993)
Fine Structure Immunocytochemistry
, pp. 137-203, Springer-Verlag, Berlin, Germany
|
| 31.
|
Slot, J. W.,
Geuze, H. J.,
Gigengack, S.,
Lienhard, G. E.,
and James, D. E.
(1991)
J. Cell Biol.
113,
123-135[Abstract/Free Full Text]
|
| 32.
|
Beckers, C. J.,
Keller, D. S.,
and Balch, W. E.
(1987)
Cell
50,
523-534[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Plutner, H.,
Davidson, H. W.,
Saraste, J.,
and Balch, W. E.
(1992)
J. Cell Biol.
119,
1097-116[Abstract/Free Full Text]
|
| 34.
|
Zhang, T.,
Wong, S. H.,
Tang, B. L.,
Xu, Y.,
and Hong, W.
(1999)
Mol. Biol. Cell
10,
435-453[Abstract/Free Full Text]
|
| 35.
|
Zhang, T.,
Wong, S. H.,
Tang, B. L.,
Xu, Y.,
Peter, F.,
Subramaniam, V. N.,
and Hong, W.
(1997)
J. Cell Biol.
139,
1157-1168[Abstract/Free Full Text]
|
| 36.
|
Zieler, H. A.,
Walberg, M.,
and Berg, P.
(1995)
Mol. Cell. Biol.
15,
3227-3237[Abstract]
|
| 37.
|
Hong, W.,
and Tang, B. L.
(1993)
Bioessays
15,
231-238[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Subramaniam, V. N.,
Peter, F.,
Philp, R.,
Wong, S. H.,
and Hong, W.
(1996)
Science
272,
1161-1163[Abstract]
|
| 39.
|
Pryer, N. K.,
Salama, N.,
Schekman, R.,
and Kaiser, C. A.
(1993)
J. Cell Biol.
120,
865-875[Abstract/Free Full Text]
|
| 40.
|
Shugrue, C. A.,
Kolen, E. R.,
Peters, H.,
Czernik, A.,
Kaiser, C.,
Matovcik, L.,
Hubbard, A. L.,
and Gorelick, F.
(1999)
J. Cell Sci.
112,
4547-4556[Abstract]
|
| 41.
|
Hara-Kuge, S. O.,
Orci, L.,
Amherdt, M.,
Ravazzola, M.,
Wieland, F. T.,
and Rothman, J. E.
(1994)
J. Cell Biol.
124,
883-892[Abstract/Free Full Text]
|
| 42.
|
Aridor, M.,
Weissman, J.,
Bannykh, S.,
Nuoffer, N.,
and Balch, W. E.
(1998)
J. Cell Biol.
141,
61-70[Abstract/Free Full Text]
|
| 43.
|
Hirst, J.,
and Robinson, M. S.
(1998)
Biochim. Biophys. Acta
1404,
173-193[Medline]
[Order article via Infotrieve]
|
| 44.
|
Shaywitz, D. A.,
Espenshade, P. J.,
Gimeno, R. E.,
and Kaiser, C. A.
(1997)
J. Biol. Chem.
272,
25413-25416[Abstract/Free Full Text]
|
| 45.
|
Gimeno, R. E.,
Espenshade, P. J.,
and Kaiser, C. A.
(1996)
Mol. Biol. Cell
7,
1815-1823[Abstract]
|
| 46.
|
Tani, K.,
Mizoguchi, T.,
Iwamatsu, A.,
Hatsuzawa, K.,
and Tagaya, M.
(1999)
J. Biol. Chem.
274,
20505-20512[Abstract/Free Full Text]
|
| 47.
|
Peng, R.,
Grabowski, R.,
De Antoni, A.,
and Gallwitz, D.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
3751-3756[Abstract/Free Full Text]
|
| 48.
|
Mongiovi, A. M.,
Romano, P. R.,
Panni, S.,
Mendoza, M.,
Wong, W. T.,
Musacchio, A.,
Cesareni, G.,
and Paolo Di Fiore, P.
(1999)
EMBO J.
18,
5300-5309[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Iinuma, T. Aoki, K. Arasaki, H. Hirose, A. Yamamoto, R. Samata, H.-P. Hauri, N. Arimitsu, M. Tagaya, and K. Tani
Role of syntaxin 18 in the organization of endoplasmic reticulum subdomains
J. Cell Sci.,
May 15, 2009;
122(10):
1680 - 1690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Wolk, B. Buchele, D. Moradpour, and C. M. Rice
A Dynamic View of Hepatitis C Virus Replication Complexes
J. Virol.,
November 1, 2008;
82(21):
10519 - 10531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Townley, Y. Feng, K. Schmidt, D. A. Carter, R. Porter, P. Verkade, and D. J. Stephens
Efficient coupling of Sec23-Sec24 to Sec13-Sec31 drives COPII-dependent collagen secretion and is essential for normal craniofacial development
J. Cell Sci.,
September 15, 2008;
121(18):
3025 - 3034.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Yamasaki, K. Tani, A. Yamamoto, N. Kitamura, and M. Komada
The Ca2+-binding Protein ALG-2 Is Recruited to Endoplasmic Reticulum Exit Sites by Sec31A and Stabilizes the Localization of Sec31A
Mol. Biol. Cell,
November 1, 2006;
17(11):
4876 - 4887.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Zhao, A. Claude, J. Chun, D. J. Shields, J. F. Presley, and P. Melancon
GBF1, a cis-Golgi and VTCs-localized ARF-GEF, is implicated in ER-to-Golgi protein traffic
J. Cell Sci.,
September 15, 2006;
119(18):
3743 - 3753.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Sannerud, M. Marie, C. Nizak, H. A. Dale, K. Pernet-Gallay, F. Perez, B. Goud, and J. Saraste
Rab1 Defines a Novel Pathway Connecting the Pre-Golgi Intermediate Compartment with the Cell Periphery
Mol. Biol. Cell,
April 1, 2006;
17(4):
1514 - 1526.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Stankewich, P. R. Stabach, and J. S. Morrow
Human Sec31B: a family of new mammalian orthologues of yeast Sec31p that associate with the COPII coat.
J. Cell Sci.,
March 1, 2006;
119(Pt 5):
958 - 969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-d. Yang, R. Elamawi, J. Bubeck, R. Pepperkok, C. Ritzenthaler, and D. G. Robinson
Dynamics of COPII Vesicles and the Golgi Apparatus in Cultured Nicotiana tabacum BY-2 Cells Provides Evidence for Transient Association of Golgi Stacks with Endoplasmic Reticulum Exit Sites
PLANT CELL,
May 1, 2005;
17(5):
1513 - 1531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Shimoi, I. Ezawa, K. Nakamoto, S. Uesaki, G. Gabreski, M. Aridor, A. Yamamoto, M. Nagahama, M. Tagaya, and K. Tani
p125 Is Localized in Endoplasmic Reticulum Exit Sites and Involved in Their Organization
J. Biol. Chem.,
March 18, 2005;
280(11):
10141 - 10148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Tai, L. Lu, T. L. Wang, B. L. Tang, B. Goud, L. Johannes, and W. Hong
Participation of the Syntaxin 5/Ykt6/GS28/GS15 SNARE Complex in Transport from the Early/Recycling Endosome to the Trans-Golgi Network
Mol. Biol. Cell,
September 1, 2004;
15(9):
4011 - 4022.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Loiodice, A. Alves, G. Rabut, M. van Overbeek, J. Ellenberg, J.-B. Sibarita, and V. Doye
The Entire Nup107-160 Complex, Including Three New Members, Is Targeted as One Entity to Kinetochores in Mitosis
Mol. Biol. Cell,
July 1, 2004;
15(7):
3333 - 3344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Netherton, I. Rouiller, and T. Wileman
The Subcellular Distribution of Multigene Family 110 Proteins of African Swine Fever Virus Is Determined by Differences in C-Terminal KDEL Endoplasmic Reticulum Retention Motifs
J. Virol.,
April 1, 2004;
78(7):
3710 - 3721.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. H. J. Aarts, O. Roovers, A. C. Ward, and I. P. Touw
Receptor activation and 2 distinct COOH-terminal motifs control G-CSF receptor distribution and internalization kinetics
Blood,
January 15, 2004;
103(2):
571 - 579.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Puri and A. D. Linstedt
Capacity of the Golgi Apparatus for Biogenesis from the Endoplasmic Reticulum
Mol. Biol. Cell,
December 1, 2003;
14(12):
5011 - 5018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Alvarez, R. Garcia-Mata, E. Brandon, and E. Sztul
COPI Recruitment Is Modulated by a Rab1b-dependent Mechanism
Mol. Biol. Cell,
May 1, 2003;
14(5):
2116 - 2127.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Horstmann, C. P. Ng, B. L. Tang, and W. Hong
Ultrastructural characterization of endoplasmic reticulum -- Golgi transport containers (EGTC)
J. Cell Sci.,
November 15, 2002;
115(22):
4263 - 4273.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. R. Hurtado and R. A. Rachubinski
Isolation and Characterization of YlBEM1, a Gene Required for Cell Polarization and Differentiation in the Dimorphic Yeast Yarrowia lipolytica
Eukaryot. Cell,
August 1, 2002;
1(4):
526 - 537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Loh and W. Hong
Sec34 Is Implicated in Traffic from the Endoplasmic Reticulum to the Golgi and Exists in a Complex with GTC-90 and ldlBp
J. Biol. Chem.,
June 7, 2002;
277(24):
21955 - 21961.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Lu, H. Horstmann, C. Ng, and W. Hong
Regulation of Golgi structure and function by ARF-like protein 1 (Arl1)
J. Cell Sci.,
March 14, 2002;
114(24):
4543 - 4555.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Adisa, F. R. Albano, J. Reeder, M. Foley, and L. Tilley
Evidence for a role for a Plasmodium falciparum homologue of Sec31p in the export of proteins to the surface of malaria parasite-infected erythrocytes
J. Cell Sci.,
March 11, 2002;
114(18):
3377 - 3386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Matynia, S. S. Salus, and S. Sazer
Three proteins required for early steps in the protein secretory pathway also affect nuclear envelope structure and cell cycle progression in fission yeast
J. Cell Sci.,
January 15, 2002;
115(2):
421 - 431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Nufer, S. Guldbrandsen, M. Degen, F. Kappeler, J.-P. Paccaud, K. Tani, and H.-P. Hauri
Role of cytoplasmic C-terminal amino acids of membrane proteins in ER export
J. Cell Sci.,
January 2, 2002;
115(3):
619 - 628.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. L. Tang, Y. S. Ong, B. Huang, S. Wei, E. T. Wong, R. Qi, H. Horstmann, and W. Hong
A Membrane Protein Enriched in Endoplasmic Reticulum Exit Sites Interacts with COPII
J. Biol. Chem.,
October 19, 2001;
276(43):
40008 - 40017.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Rust, L. Landmann, R. Gosert, B. L. Tang, W. Hong, H.-P. Hauri, D. Egger, and K. Bienz
Cellular COPII Proteins Are Involved in Production of the Vesicles That Form the Poliovirus Replication Complex
J. Virol.,
October 15, 2001;
75(20):
9808 - 9818.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Shimoni, T. Kurihara, M. Ravazzola, M. Amherdt, L. Orci, and R. Schekman
Lst1p and Sec24p Cooperate in Sorting of the Plasma Membrane ATPase into COPII Vesicles in Saccharomyces cerevisiae
J. Cell Biol.,
November 20, 2000;
151(5):
973 - 984.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. T. Hammond and B. S. Glick
Dynamics of Transitional Endoplasmic Reticulum Sites in Vertebrate Cells
Mol. Biol. Cell,
September 1, 2000;
11(9):
3013 - 3030.
[Abstract]
[Full Text]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|